Citadel Advisors

Citadel Advisors’s Entero Therapeutics ENTO Stock Holding History

Citadel Advisors’s Portfolio ENTO Stock Details ENTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.97K	Buy
2024 Q4	–	Sell
2024 Q3	$3.46K	Buy
2023 Q4	–	Sell
2023 Q3	$23.7K	Buy
2022 Q1	–	Sell
2021 Q4	$20K	Buy
2021 Q3	–	Sell
2021 Q2	$141K	Buy
2020 Q2	–	Hold
2020 Q1	–	Hold